PANews reported on May 13, according to Cointelegraph, that the list of top holders of President Donald Trump's meme coin has been determined. They will undergo background checks to apply for participation in a dinner with the President and a "VIP tour" event on May 22. According to data provided by the project's leaderboard, as of May 12, the top 220 wallets hold over 13.7 million TRUMP tokens, valued at approximately $174 million at the time of publication. It is currently unclear whether any of these wallet holders will choose to apply and attend the Trump dinner event. A report by Bloomberg on May 7 pointed out that most token holders are located outside the United States, raising potential security issues and conflicts of interest.
Wallets ranked in the top 220 by holdings at the Trump dinner collectively hold approximately $174 million worth of TRUMP tokens
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
